SYP-0704A

· Samyang Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYP-0704A, covering 2012-12-21 to 2012-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer [Phase 1]